Skip to main content
Pharmacy Market Analysis US - Size and Forecast 2024-2028

Pharmacy Market Analysis US - Size and Forecast 2024-2028

Published: Jul 2024 138 Pages SKU: IRTNTR76457

Market Overview at a Glance

$90.8 B
Market Opportunity
3.14%
CAGR
2.87
YoY growth 2023-2024(%)

US Pharmacy Market Size 2024-2028 

The US pharmacy market size is forecast to increase by USD 90.8 billion at a CAGR of 3.14% between 2023 and 2028. In the dynamic market, several drivers, trends, and challenges shape the industry landscape. The aging population in the United States is a significant growth factor, leading to an increase in pharmaceutical sales. Pharmaceutical exports, biotechnology, biosimilars, biologics, antiretroviral drugs, and vaccines are significant contributors to the sector's growth. This demographic shift also necessitates the adoption of telepharmacy services to cater to the healthcare needs of an expanding elderly population. Another trend in the market is the digitization of electronic health records (EHRs).  Additionally, rising pricing in pharmaceuticals and reimbursement pressures are predefined factors influencing market growth. Quality control and licensing are essential aspects of the market, with industry associations playing a crucial role in setting standards and ensuring regulatory compliance. According to recent survey results, retail stores and hospitals remain the key distribution channels for pharmaceuticals. 

Pharmacy Market Size

 Request Free Sample

The market encompasses a wide range of healthcare products, including prescription medications, over-the-counter drugs, and health supplements. Pharmacists play a crucial role in ensuring the safe and effective use of these products by patients. With the increasing adoption of technology in healthcare, digital solutions have become essential components of modern pharmacy services. The growth of retail and hospital pharmacies is significantly influenced by the demand for OTC medications and generic medicines, with projections tied to GDP performance, especially during the April-January period when items like hydroxychloroquine became prominent in the market for medical goods. One significant trend in the market is the integration of technology into various aspects of pharmacy operations. 

Furthermore, these digital pharmacies offer convenience and accessibility, allowing patients to order their prescriptions and over-the-counter medications from the comfort of their homes. National health services are increasingly adopting EHRs to improve patient care and streamline operations. EHRs enable pharmacists to access patients' medical histories, allergies, and medication lists, ensuring accurate and safe prescription dispensing. Technology is also transforming the production and distribution of healthcare products. API producers are leveraging digital solutions to improve the efficiency and quality of their manufacturing processes. The use of technology in the market is expected to continue growing, driven by the need for improved patient care, increased convenience, and cost savings.

Market Segmentation

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD billion" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

  • Product
    • Prescription
    • OTC
  • Ownership
    • Pharmacy chain
    • Independent
  • Type
    • Retail pharmacy
    • Hospital pharmacy
    • Others
  • Geography
    • US

By Product Insights

The Prescription segment is estimated to witness significant growth during the forecast period. Pharmaceutical businesses in the United States have leveraged the power of market segmentation to better understand consumer needs and preferences in the prescription sector. This approach allows companies to develop targeted marketing strategies, optimize inventory, and enhance overall customer satisfaction. One crucial aspect of prescription-based market segmentation involves categorizing customers based on their therapeutic requirements. These categories span various health conditions, including cardiovascular health, mental health, respiratory diseases, chronic pain management, and numerous others.

Furthermore, by segmenting the market, pharmacies ensure a comprehensive range of prescription medications for each category, enabling them to offer customized treatment solutions to their clients. The Internet's increasing penetration in the US has significantly influenced market segmentation in the pharmaceutical industry. The S-curve method, a popular analytical tool, helps visualize the growth patterns of various market segments. Exchange rates and representativeness are essential factors to consider when analyzing data from Global GCS data, a valuable resource, that provides insights into consumer behavior and trends within these segments.  By staying abreast of market trends and consumer preferences, pharmacies can cater to the unique needs of their clientele, ultimately driving customer loyalty and business success.

Pharmacy Market Size

Get a glance at the market share of various segments Request Free Sample

The prescription segment was valued at USD 425.20 billion in 2018 and showed a gradual increase during the forecast period.

Our market researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Market Driver

The increasing aging population is the key driver of the market. In the United States, the aging population is leading to a significant shift in the pharmacy industry. With the baby boomer generation entering their golden years, there is a rising need for healthcare products, including prescription medications, over-the-counter drugs, and health supplements. Pharmacies have become essential components of the healthcare system, offering medication management and medical advice to a large number of elderly patients dealing with chronic conditions such as diabetes, hypertension, and arthritis. To cater to this demographic change, pharmacists are expanding their services. They now offer medication synchronization, immunizations, and medication treatment management. Technology plays a crucial role in this transformation, with digital solutions like electronic health records and data analytics enabling pharmacists to provide personalized care.

Patients can even access their medications online, making it more convenient for them to manage their health. The market in the US is expected to grow, driven by the increasing demand for healthcare services and the adoption of advanced technology.

Market Trends

The increasing use of telepharmacy services is the upcoming trend in the market. Telepharmacy is transforming the US market by integrating technology and pharmacist expertise to enhance patient care and medication access, particularly in underserved areas. Convenience is a major driver of telepharmacy's growth, as it eliminates the need for lengthy travel to obtain prescriptions and advice. Telepharmacies offer virtual consultations, allowing patients to interact with pharmacists remotely, improving medication administration and adherence. Pharmacists can provide detailed medication information, potential side effects, and usage instructions during these consultations, ensuring patients follow treatment plans effectively.

Furthermore, pharmacists must be licensed to practice in the state where they provide services, ensuring quality control. B2C enterprises and hospitals are increasingly adopting telepharmacy to expand their offerings and improve patient care. This trend is expected to continue, revolutionizing the pharmaceutical sales landscape. Demographic changes, including an aging population and increased urbanization, are predefined factors fueling telepharmacy's expansion. Industry associations and survey results indicate a positive shift towards telepharmacy services.

Market Challenge

Rising pricing in pharmaceuticals and reimbursement pressures is a key challenge affecting the market growth. In the United States, the pharmaceutical sector encounters a multifaceted challenge, marked by escalating drug costs and mounting reimbursement pressures. This predicament poses significant implications for both patients and healthcare providers. The escalating prices of pharmaceutical products have emerged as a topic of controversy in recent years. Patients may struggle to afford essential medications, leading to delayed or inadequate treatment. The financial burden of prescription drugs can negatively impact individuals' financial stability, as well as strain healthcare systems and insurance providers. Furthermore, the pharmaceutical industry grapples with reimbursement demands from diverse sources, including public health programs and private insurance entities.

Furthermore, preventive healthcare measures, such as vitamins, supplements, health monitoring devices, health screenings, and vaccinations, assume growing importance in mitigating the impact of these challenges. Local circumstances, particularly in rural areas and underserved communities, necessitate innovative solutions. Macroeconomic factors, including inflation and regulatory changes, also influence the market dynamics of pharmaceuticals.

Exclusive Customer Landscape

The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

Pharmacy Market Share by Geography

 Customer Landscape

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Albertsons Companies Inc.: The company offers pharmacy services such as specialty care pharmacy, flu shots, and vaccines.

The market research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

  • Cardinal Health Inc.
  • CVS Health Corp.
  • Humana Inc.
  • McKesson Corp.
  • Rite Aid Corp.
  • The Cigna Group
  • The Kroger Co.
  • United Health Group Inc.
  • Walgreens Boots Alliance Inc.
  • Walmart Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Research Analyst Overview

The market encompasses a wide range of healthcare products, including prescription medications, over-the-counter drugs, health supplements, vitamins, and minerals. Pharmacists play a crucial role in dispensing these medications and providing advice on their safe and effective use. With the advent of technology, digital solutions such as electronic health records, data analytics, and telemedicine have transformed the industry. Preventive healthcare measures, like health monitoring devices, health screenings, vaccinations, and vitamins and supplements, have gained significant importance in recent years. Local special circumstances, such as rural areas and underserved communities, present unique challenges for the pharmaceutical sector. Macroeconomic factors, changing demographics, licensing, and quality control are predefined factors influencing the industry's growth.

Furthermore, B2C enterprises, including hospitals, retail stores, and e-pharmacies like Medly Pharmacy, Pharmaca, Pharmeasy, and Epharmacy, are major players in the pharmaceutical sales landscape. Pharmaceutical production involves a complex process, from raw material sourcing to manufacturing and distribution. The market is influenced by various factors, including internet penetration, industry associations, survey results, exchange rates, representativeness, GCS data, and national health services

Market Scope

Report Coverage

Details

Page number

138

Base year

2023

Historic period

2017-2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 3.14%

Market Growth 2024-2028

USD 90.8 billion

Market structure

Concentrated

YoY growth 2023-2024(%)

2.87

Key companies profiled

Albertsons Companies Inc., Cardinal Health Inc., CVS Health Corp., Humana Inc., McKesson Corp., Rite Aid Corp., The Cigna Group, The Kroger Co., United Health Group Inc., Walgreens Boots Alliance Inc., and Walmart Inc.

Market dynamics

Parent market analysis, market growth inducers and obstacles, market forecast , fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, market condition analysis for the forecast period

Customization purview

If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Competitive landscape

Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Request Free Sample

What are the Key Data Covered in this Market Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the market growth and forecasting between 2024 and 2028
  • Precise estimation of the size of the market  and its contribution of the market in focus to the parent market
  • Accurate predictions about upcoming market growth and trends and changes in consumer behaviour
  • Growth of the market across US
  • Thorough analysis of the market's competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Country Market Characteristics
    • Executive Summary - Chart on Market Segmentation by Product
    • Executive Summary - Chart on Market Segmentation by Ownership
    • Executive Summary - Chart on Market Segmentation by Type
    • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 2.2 Market characteristics
    • Market characteristics analysis
  • 2.3 Value chain analysis
    • Value Chain Analysis

3 Market Sizing

  • 3.1 Market definition
    • Offerings of companies included in the market definition
  • 3.2 Market segment analysis
    • Market segments
  • 3.3 Market size 2023
    • 3.4 Market outlook: Forecast for 2023-2028
      • Chart on US - Market size and forecast 2023-2028 ($ billion)
      • Data Table on US - Market size and forecast 2023-2028 ($ billion)
      • Chart on US: Year-over-year growth 2023-2028 (%)
      • Data Table on US: Year-over-year growth 2023-2028 (%)

    4 Historic Market Size

    • 4.1 Pharmacy Market in US 2018 - 2022
      • Historic Market Size - Data Table on Pharmacy Market in US 2018 - 2022 ($ billion)
    • 4.2 Product segment analysis 2018 - 2022
      • Historic Market Size - Product Segment 2018 - 2022 ($ billion)
    • 4.3 Ownership segment analysis 2018 - 2022
      • Historic Market Size - Ownership Segment 2018 - 2022 ($ billion)
    • 4.4 Type segment analysis 2018 - 2022
      • Historic Market Size - Type Segment 2018 - 2022 ($ billion)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Five forces analysis - Comparison between 2023 and 2028
    • 5.2 Bargaining power of buyers
      • Bargaining power of buyers - Impact of key factors 2023 and 2028
    • 5.3 Bargaining power of suppliers
      • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
    • 5.4 Threat of new entrants
      • Threat of new entrants - Impact of key factors in 2023 and 2028
    • 5.5 Threat of substitutes
      • Threat of substitutes - Impact of key factors in 2023 and 2028
    • 5.6 Threat of rivalry
      • Threat of rivalry - Impact of key factors in 2023 and 2028
    • 5.7 Market condition
      • Chart on Market condition - Five forces 2023 and 2028

    6 Market Segmentation by Product

    • 6.1 Market segments
      • Chart on Product - Market share 2023-2028 (%)
      • Data Table on Product - Market share 2023-2028 (%)
    • 6.2 Comparison by Product
      • Chart on Comparison by Product
      • Data Table on Comparison by Product
    • 6.3 Prescription - Market size and forecast 2023-2028
      • Chart on Prescription - Market size and forecast 2023-2028 ($ billion)
      • Data Table on Prescription - Market size and forecast 2023-2028 ($ billion)
      • Chart on Prescription - Year-over-year growth 2023-2028 (%)
      • Data Table on Prescription - Year-over-year growth 2023-2028 (%)
    • 6.4 OTC - Market size and forecast 2023-2028
      • Chart on OTC - Market size and forecast 2023-2028 ($ billion)
      • Data Table on OTC - Market size and forecast 2023-2028 ($ billion)
      • Chart on OTC - Year-over-year growth 2023-2028 (%)
      • Data Table on OTC - Year-over-year growth 2023-2028 (%)
    • 6.5 Market opportunity by Product
      • Market opportunity by Product ($ billion)
      • Data Table on Market opportunity by Product ($ billion)

    7 Market Segmentation by Ownership

    • 7.1 Market segments
      • Chart on Ownership - Market share 2023-2028 (%)
      • Data Table on Ownership - Market share 2023-2028 (%)
    • 7.2 Comparison by Ownership
      • Chart on Comparison by Ownership
      • Data Table on Comparison by Ownership
    • 7.3 Pharmacy chain - Market size and forecast 2023-2028
      • Chart on Pharmacy chain - Market size and forecast 2023-2028 ($ billion)
      • Data Table on Pharmacy chain - Market size and forecast 2023-2028 ($ billion)
      • Chart on Pharmacy chain - Year-over-year growth 2023-2028 (%)
      • Data Table on Pharmacy chain - Year-over-year growth 2023-2028 (%)
    • 7.4 Independent - Market size and forecast 2023-2028
      • Chart on Independent - Market size and forecast 2023-2028 ($ billion)
      • Data Table on Independent - Market size and forecast 2023-2028 ($ billion)
      • Chart on Independent - Year-over-year growth 2023-2028 (%)
      • Data Table on Independent - Year-over-year growth 2023-2028 (%)
    • 7.5 Market opportunity by Ownership
      • Market opportunity by Ownership ($ billion)
      • Data Table on Market opportunity by Ownership ($ billion)

    8 Market Segmentation by Type

    • 8.1 Market segments
      • Chart on Type - Market share 2023-2028 (%)
      • Data Table on Type - Market share 2023-2028 (%)
    • 8.2 Comparison by Type
      • Chart on Comparison by Type
      • Data Table on Comparison by Type
    • 8.3 Retail pharmacy - Market size and forecast 2023-2028
      • Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ billion)
      • Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ billion)
      • Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
      • Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
    • 8.4 Hospital pharmacy - Market size and forecast 2023-2028
      • Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion)
      • Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion)
      • Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
      • Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
    • 8.5 Others - Market size and forecast 2023-2028
      • Chart on Others - Market size and forecast 2023-2028 ($ billion)
      • Data Table on Others - Market size and forecast 2023-2028 ($ billion)
      • Chart on Others - Year-over-year growth 2023-2028 (%)
      • Data Table on Others - Year-over-year growth 2023-2028 (%)
    • 8.6 Market opportunity by Type
      • Market opportunity by Type ($ billion)
      • Data Table on Market opportunity by Type ($ billion)

    9 Customer Landscape

    • 9.1 Customer landscape overview
      • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    10 Drivers, Challenges, and Opportunity/Restraints

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Impact of drivers and challenges in 2023 and 2028
        • 10.4 Market opportunities/restraints

          11 Competitive Landscape

          • 11.1 Overview
            • 11.2 Competitive Landscape
              • Overview on criticality of inputs and factors of differentiation
            • 11.3 Landscape disruption
              • Overview on factors of disruption
            • 11.4 Industry risks
              • Impact of key risks on business

            12 Competitive Analysis

            • 12.1 Companies profiled
              • Companies covered
            • 12.2 Market positioning of companies
              • Matrix on companies position and classification
            • 12.3 Albertsons Companies Inc.
              • Albertsons Companies Inc. - Overview
              • Albertsons Companies Inc. - Product / Service
              • Albertsons Companies Inc. - Key news
              • Albertsons Companies Inc. - Key offerings
            • 12.4 Cardinal Health Inc.
              • Cardinal Health Inc. - Overview
              • Cardinal Health Inc. - Business segments
              • Cardinal Health Inc. - Key news
              • Cardinal Health Inc. - Key offerings
              • Cardinal Health Inc. - Segment focus
            • 12.5 CVS Health Corp.
              • CVS Health Corp. - Overview
              • CVS Health Corp. - Business segments
              • CVS Health Corp. - Key offerings
              • CVS Health Corp. - Segment focus
            • 12.6 Humana Inc.
              • Humana Inc. - Overview
              • Humana Inc. - Business segments
              • Humana Inc. - Key offerings
              • Humana Inc. - Segment focus
            • 12.7 McKesson Corp.
              • McKesson Corp. - Overview
              • McKesson Corp. - Business segments
              • McKesson Corp. - Key news
              • McKesson Corp. - Key offerings
              • McKesson Corp. - Segment focus
            • 12.8 Rite Aid Corp.
              • Rite Aid Corp. - Overview
              • Rite Aid Corp. - Business segments
              • Rite Aid Corp. - Key offerings
              • Rite Aid Corp. - Segment focus
            • 12.9 The Cigna Group
              • The Cigna Group - Overview
              • The Cigna Group - Product / Service
              • The Cigna Group - Key offerings
            • 12.10 The Kroger Co.
              • The Kroger Co. - Overview
              • The Kroger Co. - Product / Service
              • The Kroger Co. - Key news
              • The Kroger Co. - Key offerings
            • 12.11 United Health Group Inc.
              • United Health Group Inc. - Overview
              • United Health Group Inc. - Business segments
              • United Health Group Inc. - Key offerings
              • United Health Group Inc. - Segment focus
            • 12.12 Walgreens Boots Alliance Inc.
              • Walgreens Boots Alliance Inc. - Overview
              • Walgreens Boots Alliance Inc. - Business segments
              • Walgreens Boots Alliance Inc. - Key news
              • Walgreens Boots Alliance Inc. - Key offerings
              • Walgreens Boots Alliance Inc. - Segment focus
            • 12.13 Walmart Inc.
              • Walmart Inc. - Overview
              • Walmart Inc. - Business segments
              • Walmart Inc. - Key news
              • Walmart Inc. - Key offerings
              • Walmart Inc. - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Inclusions checklist
                • Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Currency conversion rates for US$
              • 13.4 Research methodology
                • Research methodology
              • 13.5 Data procurement
                • Information sources
              • 13.6 Data validation
                • Data validation
              • 13.7 Validation techniques employed for market sizing
                • Validation techniques employed for market sizing
              • 13.8 Data synthesis
                • Data synthesis
              • 360 degree market analysis
                • 360 degree market analysis
              • 13.10 List of abbreviations
                • List of abbreviations

              Research Methodology

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              Interested in this report?

              Get your sample now to see our research methodology and insights!

              Download Now

              Frequently Asked Questions

              Pharmacyin US market growth will increase by $ 90.8 bn during 2024-2028.

              The Pharmacyin US market is expected to grow at a CAGR of 3.14% during 2024-2028.

              Pharmacyin US market is segmented by Product( Prescription, OTC) Ownership( Pharmacy chain, Independent) Type( Retail pharmacy, Hospital pharmacy, Others)

              Albertsons Companies Inc., Cardinal Health Inc., CVS Health Corp., Humana Inc., McKesson Corp., Rite Aid Corp., The Cigna Group, The Kroger Co., United Health Group Inc., Walgreens Boots Alliance Inc., Walmart Inc. are a few of the key vendors in the Pharmacyin US market.

              North America will register the highest growth rate of 100% among the other regions. Therefore, the Pharmacyin US market in North America is expected to garner significant business opportunities for the vendors during the forecast period.

              US

              • Increasing aging populationThe US is going through a major demographic change is the driving factor this market.
              • and it is having a huge impact on the pharmacy industry. As America's baby boomers get older is the driving factor this market.
              • they're turning to pharmaceuticals and healthcare services more and more. As the population ages is the driving factor this market.
              • there is an increased demand for prescription drugs to treat chronic conditions is the driving factor this market.
              • including diabetes is the driving factor this market.
              • hypertension is the driving factor this market.
              • and arthritis. Consequently is the driving factor this market.
              • pharmacies are becoming an increasingly important part of the healthcare system is the driving factor this market.
              • as they are the primary point of entry for many elderly patients who require medication management and medical advice. Pharmacists are responding to the changing needs of this demographic by providing services like medication synchronization is the driving factor this market.
              • immunization is the driving factor this market.
              • and medication treatment management. Not only does this improve patient care is the driving factor this market.
              • but it also increases the bottom line of pharmacies. In addition is the driving factor this market.
              • the increasing number of elderly patients opens the door for pharmacies to diversify their services is the driving factor this market.
              • such as providing home delivery and Telep pharmacy services to meet the needs of those who may be restricted in their mobility or prefer to consult at a distance. Additionally is the driving factor this market.
              • pharmacies are exploring ways to collaborate with healthcare providers as well as insurance companies to provide coordinated and integrated care for the elderly. These factors will expand the growth of the pharmacy market in US during the forecast period. is the driving factor this market.

              The Pharmacyin US market vendors should focus on grabbing business opportunities from the Prescription segment as it accounted for the largest market share in the base year.
              RIA - Research AI Assistant
              Ask RIA